Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No substantive changes detected; core study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T12:54:42.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a site revision tag (Revision: v3.4.2) and removed older funding-status notices (Revision: v3.4.1). These changes affect only the site metadata and do not modify the study details or eligibility information.
    Difference
    0.5%
    Check dated 2026-02-11T06:14:43.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operations was added. The site revision number was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:51:50.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a page revision note 'Revision: v3.4.0'. Older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed and the revision updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T02:50:49.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:16:11.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section listing Massachusetts as a site, replacing the previous Massachusetts Locations subsection. A revision note shows the page updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:18:36.000Z thumbnail image

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.